HIE - Hypoxic - Ischemic Encephalopathy: Clinical Trials

7 trials for HIE - Hypoxic - Ischemic Encephalopathy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 not yet recruiting, 3 recruiting, 1 unknown. 2 Phase 3, 1 Phase 2, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 32Not yet recruiting 2
Phase 21Not yet recruiting 1
Phase 41Not yet recruiting 1

Follow HIE - Hypoxic - Ischemic Encephalopathy: new trials by email Literature Review of HIE - Hypoxic - Ischemic Encephalopathy trials Research Report on HIE - Hypoxic - Ischemic Encephalopathy

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Intranasal Stem Cells to Treat Perinatal Brain Injury to Combat Cerebral Palsy
MSC, marrow, Placebo - Perinatal Arterial Ischemic Stroke, Perinatal Asphyxia
Phase 2 / Phase 3Not yet recruitingUMC Utrecht1622027-04-012026-09-21
COMPARISON OF OUTCOME OF HYPOXIC ISCHEMIC ENCEPHLOPATHY MANAGED WITH COMBINATION OF MAGNESIUM SULPHATE AND MELATONIN VERSUS MAGNESIUM SULPHATE ALONE
MgSO4 (seizure prevention), Melatonin , Mgso4 - HIE - Hypoxic - Ischemic Encephalopathy
Phase 3Not yet recruitingUniversity of Child Health Sciences and Children's Hospital, Lahore802026-07-012026-06-17
Treatment of Seizures in Neonate With HIE
Phenobarbital, Levetiracetam - Neonatal Seizures, HIE - Hypoxic - Ischemic Encephalopathy
Phase 4Not yet recruitingMansoura University662026-01-012025-12-16
Speech of Kids After Neonatal Encephalopathy
HIE - Hypoxic - Ischemic Encephalopathy, Language Delay
RecruitingSemmelweis University932025-04-012025-08-22
Assessing Intellectual and Motor Outcomes in High-risk Infants
Cerebral Palsy, Cerebral Palsy (CP)
RecruitingUniversity College Cork6002025-03-212026-05-13
Biomarkers Study in Infants With Prior Neonatal Brain Injury
HIE - Hypoxic - Ischemic Encephalopathy, Perinatal Anoxic-ischemic Brain Injury
RecruitingUniversity of Wisconsin, Madison1002023-03-132026-02-17
Effect of Targeted Temperature Management on Cerebral Autoregulation in Patients With Neurocritical Diseases
Ischemic Stroke, Subarachnoid Hemorrhage, Aneurysmal
UnknownXiangya Hospital of Central South University1002021-01-222021-01-28

Narrower conditions

Hypoxia-Ischemia, Brain (2)  ·  Premature Birth (2)  ·  Attention Deficit Disorder with Hyperactivity (1)  ·  Autistic Disorder (1)  ·  Brain Injuries, Traumatic (1)  ·  Cerebral Hemorrhage (1)  ·  Cerebral Palsy (1)  ·  Cognitive Dysfunction (1)  ·  Developmental Disabilities (1)  ·  Intellectual Disability (1)  ·  Ischemic Stroke (1)  ·  Language Development Disorders (1)  ·  Sepsis (1)  ·  Specific Language Disorder (1)  ·  Subarachnoid Hemorrhage (1)

Broader conditions

Nervous System Diseases (4)  ·  Pathological Conditions, Signs and Symptoms (4)  ·  Brain Diseases (3)  ·  Cardiovascular Diseases (3)  ·  Central Nervous System Diseases (3)  ·  Cerebrovascular Disorders (3)  ·  Signs and Symptoms (3)  ·  Vascular Diseases (3)  ·  Brain Ischemia (2)  ·  Female Urogenital Diseases and Pregnancy Complications (2)  ·  Hypoxia (2)  ·  Hypoxia, Brain (2)  ·  Mental Disorders (2)  ·  Neurodevelopmental Disorders (2)  ·  Obstetric Labor Complications (2)

Interventions

Levetiracetam (1)  ·  Magnesium Sulfate (1)  ·  Melatonin (1)  ·  Phenobarbital (1)

Sponsors

Mansoura University (1)  ·  Semmelweis University (1)  ·  UMC Utrecht (1)  ·  University College Cork (1)  ·  University of Child Health Sciences and Children's Hospital, Lahore (1)  ·  University of Wisconsin, Madison (1)  ·  Xiangya Hospital of Central South University (1)

Countries

China (1)  ·  Egypt (1)  ·  Hungary (1)  ·  Ireland (1)  ·  United States (1)

Top investigators

Deirdre M Murray (1)  ·  Lina Zhang, PhD (1)  ·  Melisa Carrasco McCaul, MD, PhD (1)  ·  Moetaza Soliman, Associate Professor (1)  ·  Nada Abdelfattah, Associate Professor (1)

Results publications

PMID 15791116, PMID 32385134, PMID 34124790, PMID 34867732, PMID 35311411, PMID 35673948, PMID 36401982, PMID 36578326, PMID 36823477, PMID 42575547, PMID 987769

NIH funding

2025 (1)